SUSPENDED

3D Printed Breast Models in the Surgical Management of Breast Cancer

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

To learn if providing a 3-D printed model of the breast can help breast cancer patients make decisions related to their care. During this study, some study participants will receive the 3-D printed model and some study participants will receive traditional breast imaging scans to learn if the 3-D printed model

Official Title

3D Printed Breast Models in the Surgical Management of Breast Cancer

Quick Facts

Study Start:2024-02-29

Study Completion:2028-02-28

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:SUSPENDED

Study ID

NCT05755984

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* Age 18 or older female * Patient must have histologically confirmed breast malignancy * Patient is a candidate for surgical management * Patient has a surgeon at MDACC (main campus and/or Houston Area Locations) * Patient has a breast MRI for extent of disease assessment at MDACC (main campus and/or Houston Area Locations). * Patient is able to speak, read or write English * Patient is willing to be randomized to the control or 3D printed breast model groups and is willing to sign the consent form.	* Pregnant and breastfeeding patients * Patients who had history of mastectomy, have recurrent malignancies on the mastectomy side * Patients for whom it is not feasible to create a 3D printed breast model from breast MRI

Inclusion Criteria

Exclusion Criteria

* Age 18 or older female
* Patient must have histologically confirmed breast malignancy
* Patient is a candidate for surgical management
* Patient has a surgeon at MDACC (main campus and/or Houston Area Locations)
* Patient has a breast MRI for extent of disease assessment at MDACC (main campus and/or Houston Area Locations).
* Patient is able to speak, read or write English
* Patient is willing to be randomized to the control or 3D printed breast model groups and is willing to sign the consent form.

* Pregnant and breastfeeding patients
* Patients who had history of mastectomy, have recurrent malignancies on the mastectomy side
* Patients for whom it is not feasible to create a 3D printed breast model from breast MRI

Contacts and Locations

Principal Investigator

Lauren Chang Sen, MD

PRINCIPAL_INVESTIGATOR

M.D. Anderson Cancer Center

Study Locations (Sites)

M D Anderson Cancer Center

Houston, Texas, 77030

United States

Collaborators and Investigators

Sponsor: M.D. Anderson Cancer Center

Lauren Chang Sen, MD, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-02-29

Study Completion Date2028-02-28

Study Record Updates

Study Start Date2024-02-29

Study Completion Date2028-02-28

Terms related to this study

Additional Relevant MeSH Terms

Breast Cancer